During the past few years, we have developed encouraging evidence from investigating disease resistance of NOD-gld/+ mice (Figure 3) and prevention of diabetes development in NOD-wt mice using a FasL-neutralizing mAb (Figure 4). Here, FASLG is linked to diabetes mellitus.